Kalincik, T. Et Al. 2016. Individual response to disease modifying therapies: a global observational cohort study. 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , (London, Canada), 358-360.

Kalincik, T., Sobisek, L., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., ... Trojano, M.(2016). Individual response to disease modifying therapies: a global observational cohort study . 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) (pp.358-360). London, Canada

Kalincik, T. Et Al. "Individual response to disease modifying therapies: a global observational cohort study," 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 2016

Kalincik, T. Et Al. "Individual response to disease modifying therapies: a global observational cohort study." 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , London, Canada, pp.358-360, 2016

Kalincik, T. Et Al. (2016) . "Individual response to disease modifying therapies: a global observational cohort study." 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , London, Canada, pp.358-360.

@conferencepaper{conferencepaper, author={T. Kalincik Et Al. }, title={Individual response to disease modifying therapies: a global observational cohort study}, congress name={32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)}, city={London}, country={Canada}, year={2016}, pages={358-360} }